Institut Pasteur du Cambodge

04/02/2026

The Institut Pasteur du Cambodge (IPC) is looking for a 𝐁𝐢𝐨𝐛𝐚𝐧𝐤 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐢𝐚𝐧 based in Hygiene Security Quality Metrology Service (HSEQM).
Read more: https://www.pasteur-kh.org/2026/02/04/biobank-technician-within-hseqm-service/
Deadline: 𝐌𝐚𝐫𝐜𝐡 𝟏𝟓𝐭𝐡, 𝟐𝟎𝟐𝟔

04/02/2026

The Institut Pasteur du Cambodge (IPC) is looking for a 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐀𝐜𝐭𝐢𝐯𝐢𝐭𝐢𝐞𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐧𝐚𝐠𝐞𝐫.
Read more: https://www.pasteur-kh.org/2026/02/04/service-activities-development-manager/
Deadline: 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐫𝐞𝐯𝐢𝐞𝐰𝐞𝐝 𝐨𝐧 𝐚 𝐫𝐨𝐥𝐥𝐢𝐧𝐠 𝐛𝐚𝐬𝐢𝐬 𝐚𝐬 𝐭𝐡𝐞𝐲 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐰𝐢𝐥𝐥 𝐫𝐞𝐦𝐚𝐢𝐧 𝐨𝐩𝐞𝐧 𝐮𝐧𝐭𝐢𝐥 𝐚 𝐬𝐮𝐢𝐭𝐚𝐛𝐥𝐞 𝐜𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞 𝐢𝐬 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝

03/02/2026

𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭 𝐏𝐚𝐬𝐭𝐞𝐮𝐫 𝐝𝐮 𝐂𝐚𝐦𝐛𝐨𝐝𝐠𝐞 (𝐈𝐏𝐂) 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐚 𝐬𝐭𝐮𝐝𝐲 𝐨𝐧 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐌𝐩𝐨𝐱 𝐨𝐮𝐭𝐛𝐫𝐞𝐚𝐤 𝐢𝐧 𝐂𝐚𝐦𝐛𝐨𝐝𝐢𝐚, 𝐰𝐡𝐢𝐜𝐡 𝐨𝐜𝐜𝐮𝐫𝐫𝐞𝐝 𝐢𝐧 𝐏𝐡𝐧𝐨𝐦 𝐏𝐞𝐧𝐡 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝟐𝟎𝟐𝟒.

By combining epidemiological investigations (who was infected and how) with whole-genome sequencing of the virus, researchers showed that all confirmed cases belonged to the same viral group (Clade IIb, lineage C.1). This means the outbreak most likely started from one introduction of the virus, followed by local transmission between people.

The study found that transmission mainly occurred through close and intimate contact within connected social networks. No cases reported recent international travel or contact with animals, suggesting the outbreak was driven by local spread rather than repeated introductions from abroad.

This work shows how genomic epidemiology helps health authorities understand how viruses spread and supports more targeted public health responses. It also shows how regional viral strains can spread into new countries, emphasizing the need for ongoing surveillance and strong laboratory capacity. The study was carried out in collaboration with the Cambodian Ministry of Health and the Institute of Tropical Medicine.

Read the publication here: https://pubmed.ncbi.nlm.nih.gov/41575511/

02/02/2026

[English Below]

ការបោះពុម្ពផ្សាយអត្ថបទវិទ្យាសាស្រ្តថ្មី

យើងខ្ញុំមានសេចក្តីរីករាយ ចែករំលែកការបោះពុម្ពផ្សាយអត្ថបទវិទ្យាសាស្រ្តថ្មីមួយ ដោយលោក Herman Banza Kongolo និស្សិតថ្នាក់បណ្ឌិតនៅផ្នែកអេពីដេមីសាស្រ្ត និង សុខភាពសាធារណៈ នៃវិទ្យាស្ថានប៉ាស្ទ័រកម្ពុជា ស្តីពីការពិនិត្យលើភាពពេញលេញតាមចំនួនដូស នៃការទទួលថ្នាំបង្ការជំងឺឆ្កែឆ្កួតក្រោយរងរបួសបង្កដោយសត្វ (PEP) នៅក្នុងប្រទេសកម្ពុជា។

ទិន្នន័យទទួលបានពីអ្នកដែលបានមកទទួលថ្នាំបង្ការនៅមជ្ឈមណ្ឌលបង្ការជំងឺឆ្កែឆ្កួត នៃវិទ្យាស្ថានប៉ាស្ទ័រកម្ពុជា ចំនួនប្រមាណ 240,000 នាក់ ក្នុងរវាងឆ្នាំ 2019 និង 2022។ ការសិក្សានេះបានកំណត់កត្តាសំខាន់ៗនាំអោយទទួលថ្មាំបង្ការ PEP មិនបានគ្រប់ដូសពេញលេញ ដោយរំលេចនូវតួនាទីនៃ កត្តាភូមិសាស្រ្ត កត្តាប្រជាសាស្ត្រនិងសង្គម និងព្រឹត្តិការណ៍នាៗ ដូចជាការកំរិតការធ្វើដំណើរក្នុងបរិបទជំងឺ កូវីដ១៩ ជាដើម។

លទ្ធផលទាំងនេះផ្តល់នូវភស្តុតាងសំខាន់ៗ ដើម្បីអាចប៉ាន់ប្រមាណបន្ទុកនៃជំងឺឆ្កែឆ្កួត កំណត់ក្រុមប្រជាជនដែលមានហានិភ័យខ្ពស់ និងជូនដំណឹងអំពីយុទ្ធសាស្ត្របង្ការជំងឺឆ្កែឆ្កួតឲ្យកាន់តែមានសមភាព និងប្រសិទ្ធភាព ស្របតាមគោលដៅសកល “គ្មានអ្នកស្ថាប់ដោយជំងឺឆ្កែឆ្កួត ឆ្លងពីសត្វឆ្កែ Zero by 30” ។

ការបោះពុម្ពផ្សាយនេះឆ្លុះបញ្ចាំងពីការខិតខំប្រឹងប្រែងរួមគ្នារបស់ផ្នែកជាច្រើននៃវិទ្យាស្ថានប៉ាស្ទ័រកម្ពុជា។ យើងសូមកោតសរសើរជាពិសេសចំពោះលោក វេជ្ជ. ពឹង យ៉ីកស៊ីង ជាប្រធាន និងក្រុមការងារ នៃផ្នែកថ្នាំបង្ការ នៃវិទ្យាស្ថានប៉ាស្ទ័រកម្ពុជា សចំពោះការប្តេជ្ញាចិត្តយូរអង្វែងរបស់ពួកគេក្នុងការផ្តល់ថ្នាំបង្ការ ការប្រមូលទិន្នន័យ និងការគាំទ្រផ្នែកប្រតិបត្តិការ ដែលបានធ្វើឲ្យការវិភាគទិន្នន័យនេះអាចសម្រេចទៅបាន។

ការងារនេះបានរួមចំណែកដល់គោលបំណងនៃគម្រោងសិក្សាស្រាវជ្រាវ VIRAGE ដែលទទួលបានមូលនិធិពីក្រសួងអឺរ៉ុប និងកិច្ចការបរទេសនៃប្រទេសបារាំង តាមរយៈស្ថានទូតបារាំង និងបង្ហាញអោយឃើញថា ទិន្នន័យបានពីការតាមដានរយៈពេលវែង អាចយកមកបកស្រាយជាចំណេះដឹងដែលនាំទៅដល់កម្មភាពជាក់ស្តែង ផ្នែកសុខភាពសាធារណៈ ។

👏 អបអរសាទរចំពោះលោក Herman Banza Kongolo និងសហការីទាំងអស់ ចំពោះការចូលរួមចំណែកដ៏សំខាន់នេះ។

អត្ថបទពេញលេញ៖ https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013813

We are pleased to share the publication of a new scientific article led by Banza Kongolo, PhD student at the Epidemiology and Public Health Unit of Institute Pasteur de Cambodge, examining rabies post-exposure prophylaxis (PEP) completion in Cambodia.

Using data from more than 240,000 patients attending IPC Rabies Prevention Centers for vaccination between 2019 and 2022, the study identifies key drivers of PEP non-completion, highlighting the critical role of geographic accessibility, socio-demographic factors, and contextual events such as COVID-19-related restrictions.

These findings provide essential evidence to better estimate the burden of rabies, identify populations at higher risk, and inform more equitable and effective rabies-prevention strategies, in line with the global in line with the global “Zero by 30” initiative, which aims to eliminate dog-mediated human rabies deaths by 2030.

This publication reflects a collective effort involving multiple teams across IPC. We would like to especially acknowledge Dr. Peng Yiksing, Director, and the Rabies Prevention Center teams for their long-standing commitment to patient care, data collection, and operational support, which made this analysis possible.

This work contributes to the scientific objectives of the VIRAGE study, funded by the French Ministry for Europe and Foreign Affairs through the French Embassy, and illustrates how long-term surveillance data can be translated into actionable public-health insights.

👏 Congratulations to Herman and all colleagues involved for this important contribution!

Read the full article: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013813

02/02/2026

𝐈𝐏𝐂 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫 𝟐𝟎𝟐𝟔 𝐚𝐧𝐝 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐍𝐞𝐰 𝐒𝐭𝐚𝐟𝐟 𝐃𝐞𝐥𝐞𝐠𝐚𝐭𝐞𝐬.

On Thursday, 29 January 2026, the Institut Pasteur du Cambodge (IPC) celebrated the New Year 2026 and welcomed the newly appointed staff delegates.

During the event, after extending his New Year wishes to all Institute staff and their families, the Director of IPC recalled several key milestones of 2025, including major achievements in research, public health, and service activities. He also highlighted the successes of several young Cambodian scientists who defended their PhD theses or were integrated into the Institut Pasteur Network’s scientific corps.

The Director and the Deputy Director, Dr Sowath Ly, emphasized the importance of staff representation, open dialogue, and collective engagement. Each staff delegate also said a few words, reaffirming their commitment to collaboration and the Institute’s values.

30/01/2026

27/01/2026

𝐈𝐏𝐂 𝐰𝐞𝐥𝐜𝐨𝐦𝐞𝐝 𝐚 𝐧𝐞𝐰 𝐦𝐞𝐦𝐛𝐞𝐫: 𝐁𝐥𝐚𝐧𝐝𝐢𝐧𝐞 𝐑𝐚𝐦𝐦𝐚𝐞𝐫𝐭

Blandine Rammaert was appointed Head of the Clinical Research Group in Epidemiology & Public Health at the Institut Pasteur du Cambodge.

She completed her clinical fellowship at Necker–Enfants Malades Hospital in Paris, within the Infectious and Tropical Diseases Unit, where she specialized in the management of infectious diseases in immunocompromised patients. In 2015, she joined the CHU de Poitiers in the Department of Internal Medicine and Infectious and Tropical Diseases and was appointed Professor (PU-PH) in September 2019.

She was deeply involved in fundamental, experimental, and clinical research. She obtained a PhD in microbiology at the Institut Pasteur in Paris, within the Molecular Mycology Unit, where her research focused on the pathophysiology of invasive fungal diseases, with a strong emphasis on immunological mechanisms and in vivo models. After joining Poitiers, she continued her research activities at INSERM U1070, a unit specialized in the pharmacology of anti-infective therapies.

In parallel, she developed and led extensive clinical research programs addressing vaccination strategies in immunocompromised patients, infectious complications in asplenic and cancer patients, invasive fungal diseases, and respiratory infections, and served as principal investigator in several phase II and III clinical trials.

She was also actively engaged in international public health and training, teaching for several years during missions for the National Tuberculosis Program in Lao PDR. She spent one year at the Institut Pasteur du Cambodge contributing to the SISEA regional respiratory infection surveillance project and later served as Head of the Infectiology and Public Health Unit at the Institut Pasteur du Laos, where she designed tuberculosis and One Health programs.

26/01/2026

The Institut Pasteur du Cambodge (IPC) is looking for a 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐨𝐜𝐭𝐨𝐫 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐁𝐚𝐭𝐭𝐚𝐦𝐛𝐚𝐧𝐠 𝐑𝐚𝐛𝐢𝐞𝐬 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐞𝐫 based in Battambang Province.
Read more: https://www.pasteur-kh.org/2025/12/17/elementor-18304/
Deadline Extend: 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟐𝟑𝐭𝐡, 𝟐𝟎𝟐𝟔

21/01/2026

𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐞 𝐨𝐟 𝐀𝐩𝐩𝐫𝐞𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐛𝐲 𝐌𝐫. 𝐋𝐢𝐦 𝐇𝐨𝐤𝐤𝐞𝐚𝐧, 𝐈𝐏𝐂’𝐬 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐁𝐒𝐋-𝟑 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐢𝐧𝐢𝐬𝐭𝐞𝐫 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡

On January 19th, HE Prof CHHEANG Ra Minister of Health presided over the inauguration of the Laboratory Building and the Biosafety Level 3 (BSL-3) facility of the National Institute of Public Health.

On this occasion , Mr. LIM Hokkean, Head of Health, Safety, Quality & Maintenance-Metrology (HSeQM) and General BSL-3 Manager, received a Certificate of Appreciation from the Minister of Health.

This recognition highlights the Institut Pasteur du Cambodge’s contribution to technical expertise and capacity building in collaboration with national public institutions.

19/01/2026

𝐅𝐫𝐨𝐦 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐖𝐚𝐬𝐭𝐞 𝐭𝐨 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧

In December, Institut Pasteur du Cambodge’s CoLab team brought a simple but powerful idea to the BioPREVAIL Design Challenge Showcase Event in Geneva: laboratory waste can be transformed into a sustainable solution.

Over three months, the team piloted a waste-to-resource system that turns plastic lab waste into new laboratory consumables. This work reflects a One Health mindset, recognizing that strengthening biosecurity and biosafety also goes hand in hand with caring for the environment and the systems that support global health.

Represented by Ms. Sofia Perez and Mr. LIM Hokkean Lim, the CoLab team shared with scientists, global health partners, funders, and collaborators how local resources, technical expertise, and creativity can lead to practical solutions for greener laboratories with lasting impact.

GlobalHealthSecurityFund, BioPREVAIL.

16/01/2026

𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭 𝐏𝐚𝐬𝐭𝐞𝐮𝐫 𝐝𝐮 𝐂𝐚𝐦𝐛𝐨𝐝𝐠𝐞‘𝐬 𝐁𝐢𝐨𝐬𝐚𝐟𝐞𝐭𝐲 𝐋𝐞𝐯𝐞𝐥 𝟑 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲.

The Institut Pasteur du Cambodge (IPC) is pleased to announce that our Biosafety Level 3 Laboratory (BSL3 Laboratory) has obtained the certification standard ISO 35001:2019 Biorisk Management from the MUTU International, a public company operating in the field of Testing, Inspection, and Certification based in Indonesia.

IPC is proud of this achievement, which concerns a laboratory enabling the safe handling of dangerous pathogens and demonstrates the Institute’s commitment to biosafety.